WAKE FOREST, NC and Canton, OH -- August 28, 2008 -- Digital Healthcare, a Wake Forest, NC company specializing in risk assessment for diabetics, recently announced that Northeast Ohio Endocrinology, based in Canton, OH, has selected the Retasure™ solution to provide retinal imaging risk assessment.

Retasure™, a telemedicine solution developed by Digital Healthcare, can detect early damage to the retina caused by diabetes, glaucoma and other conditions.

“Thousands more diabetic patients in Ohio now have access to sight-saving technology thanks to the foresight of Northeast Ohio Endocrinology,” said Scott Sanner, Senior Vice President, North American Operations of Digital Healthcare.  “Dr. Wietecha and his team are leading the way in improving the lives of their diabetic patients”

Dr. Wietecha and has been practicing medicine since 1991. He received his medical degree from Michigan State College of Osteopathic Medicine. Dr. Wietecha is extensively published in many medical journals, and is board certified in Internal Medicine, Endocrinology and Metabolism.  Dr. Wietecha and Dr. Irina Korableva both obtained their Fellowship in Endocrinology, Metabolism, and Bone Mineral Diseases from Henry Ford Hospital, Detroit, Michigan. Both are board certified in Internal Medicine, Endocrinology and Metabolism.

The FDA-approved and HEDIS compliant Retasure™ solution provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients’ retinal images during a three to five minute procedure. Images are transmitted over a secure, HIPAA compliant network to an accredited reading center. A state-licensed and board-certified ophthalmologist reviews the images and results are returned to the original physician within 72 hours.

There are an estimated 20 million diabetic patients in the US, but only about half have any retinal assessments, despite a high risk of diabetic retinopathy. The National Eye Institute indicates diabetic retinopathy is the leading cause of blindness among working age American adults. More than a million patients around the world have received a retinal risk assessment using Digital Healthcare software.

About Digital Healthcare
Digital Healthcare is the global leader in retinal risk assessment. They are the world’s leading provider of care management programs for diabetic retinopathy. Their award-winning MS-HUG technology is used by leading hospitals and research centers including University Hospitals Case Medical Center at Case Western Reserve University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military. Digital Healthcare’s Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to the ordering physicians; and it encourages patient compliance for retinal evaluation and comprehensive eye examinations.

Media Contact:
Scott Sanner
This email address is being protected from spam bots, you need Javascript enabled to view it
www.retasure.com

###